Use of extracorporeal membrane oxygenation in a patient with diffuse alveolar hemorrhage

Shah-hinan Ahmed, Tariq Aziz, Joel Cochran, Kristin Highland

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

Extracorporeal membrane oxygenation (ECMO) was developed as a supportive therapy for severe respiratory failure. It has been shown to be life-saving in neonates and children with isolated respiratory failure, however, its usefulness in adults remains controversial. We report the successful use of ECMO in an adult patient with severe hypoxemic respiratory failure secondary to diffuse alveolar hemorrhage from Wegener granulomatosis.

Original languageEnglish (US)
Pages (from-to)305-309
Number of pages5
JournalChest
Volume126
Issue number1
DOIs
StatePublished - Jul 2004
Externally publishedYes

Fingerprint

Extracorporeal Membrane Oxygenation
Respiratory Insufficiency
Hemorrhage
Granulomatosis with Polyangiitis
Newborn Infant
Therapeutics

Keywords

  • Aminocaproic acid
  • Antineutrophil cytoplasmic antibody
  • Diffuse alveolar hemorrhage
  • Extracorporeal membrane oxygenation
  • Respiratory failure
  • Vasculitis
  • Wegener's granulomatosis

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Use of extracorporeal membrane oxygenation in a patient with diffuse alveolar hemorrhage. / Ahmed, Shah-hinan; Aziz, Tariq; Cochran, Joel; Highland, Kristin.

In: Chest, Vol. 126, No. 1, 07.2004, p. 305-309.

Research output: Contribution to journalArticle

Ahmed, Shah-hinan ; Aziz, Tariq ; Cochran, Joel ; Highland, Kristin. / Use of extracorporeal membrane oxygenation in a patient with diffuse alveolar hemorrhage. In: Chest. 2004 ; Vol. 126, No. 1. pp. 305-309.
@article{24c98510ffd3494082a463340c14c8ed,
title = "Use of extracorporeal membrane oxygenation in a patient with diffuse alveolar hemorrhage",
abstract = "Extracorporeal membrane oxygenation (ECMO) was developed as a supportive therapy for severe respiratory failure. It has been shown to be life-saving in neonates and children with isolated respiratory failure, however, its usefulness in adults remains controversial. We report the successful use of ECMO in an adult patient with severe hypoxemic respiratory failure secondary to diffuse alveolar hemorrhage from Wegener granulomatosis.",
keywords = "Aminocaproic acid, Antineutrophil cytoplasmic antibody, Diffuse alveolar hemorrhage, Extracorporeal membrane oxygenation, Respiratory failure, Vasculitis, Wegener's granulomatosis",
author = "Shah-hinan Ahmed and Tariq Aziz and Joel Cochran and Kristin Highland",
year = "2004",
month = "7",
doi = "10.1378/chest.126.1.305",
language = "English (US)",
volume = "126",
pages = "305--309",
journal = "Chest",
issn = "0012-3692",
publisher = "American College of Chest Physicians",
number = "1",

}

TY - JOUR

T1 - Use of extracorporeal membrane oxygenation in a patient with diffuse alveolar hemorrhage

AU - Ahmed, Shah-hinan

AU - Aziz, Tariq

AU - Cochran, Joel

AU - Highland, Kristin

PY - 2004/7

Y1 - 2004/7

N2 - Extracorporeal membrane oxygenation (ECMO) was developed as a supportive therapy for severe respiratory failure. It has been shown to be life-saving in neonates and children with isolated respiratory failure, however, its usefulness in adults remains controversial. We report the successful use of ECMO in an adult patient with severe hypoxemic respiratory failure secondary to diffuse alveolar hemorrhage from Wegener granulomatosis.

AB - Extracorporeal membrane oxygenation (ECMO) was developed as a supportive therapy for severe respiratory failure. It has been shown to be life-saving in neonates and children with isolated respiratory failure, however, its usefulness in adults remains controversial. We report the successful use of ECMO in an adult patient with severe hypoxemic respiratory failure secondary to diffuse alveolar hemorrhage from Wegener granulomatosis.

KW - Aminocaproic acid

KW - Antineutrophil cytoplasmic antibody

KW - Diffuse alveolar hemorrhage

KW - Extracorporeal membrane oxygenation

KW - Respiratory failure

KW - Vasculitis

KW - Wegener's granulomatosis

UR - http://www.scopus.com/inward/record.url?scp=3242733343&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3242733343&partnerID=8YFLogxK

U2 - 10.1378/chest.126.1.305

DO - 10.1378/chest.126.1.305

M3 - Article

C2 - 15249477

AN - SCOPUS:3242733343

VL - 126

SP - 305

EP - 309

JO - Chest

JF - Chest

SN - 0012-3692

IS - 1

ER -